A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PICCHA BASTI WITH BALAGUDUCCHYADI TAILA MATRA BASTI IN THE MANAGEMENT OF ASRIGDAR W.S.R. ABNORMAL UTERINE BLEEDING.

ABNORMAL UTERINE BLEEDING DEFINED AS ANY DEVIATION FROM THE NORMAL MENSTRUAL CYCLE IN TERMS OF FREQUENCY DURATION REGULARITY OR VOLUME OF BLOOD FLOW THAT IS NOT RELATED TO PREGNANCY. IT AFFECTS WOMENS PHYSICAL,SOCIAL,EMOTIONAL WELL BEING.WHILE CONVENTIONAL TREATMENTS OFFERS  SYMPTOMATIC RELIEF THEY ARE ASSOCIATED WITH SIDE EFFECTS AND MAY NOT BE SUITABLE FOR ALL PATIENTS.THIS RANDOMIZATION OPEN LABEL COMPARATIVE CLINICAL STUDY IS TO EVALUATE THE EFFICACY OF PICCHA BASTI WITH BALAGUDUCHYADI TAILA MATRA BASTI .THE STUDY INVOLVES 40 PARTICIPANTS WHO ARE DIAGNOSED WITH AUB BASED ON CLINICAL EVALUATION AND SUPPORTING INVESTIGATIONS.PICCHA BASTI KNOWN FOR ITS ASTRINGENT PROPERTY AND BALAGUCHYADI TAILA FOR A NUTRITIVE AND VATA PACIFYING AYURVEDIC FORMULATION FOR MANAGING ASRIGDAR.THIS WILL BE ADMINISTERED FOR 3 MONTHS AIMING TO REDUCE SYMPTOMS SUCH AS EXCESSIVE MENSTRUAL BLEEDING,INTERMENSTRUAL BLEEDING,AND OTHER SYMPTOMS.OUTCOME MEASURE WILL INCLUDE BOTH SUBJECTIVE AND OBJECTIVE PARAMETERS .THIS STUDY WILL OFFER A POTENTIALLY SAFER ALTERNATIVE TO CONVENTIONAL TREATMENT.